Form 4: OnKure Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Jason A. Leverone, Chief Financial Officer of OnKure Therapeutics, Inc., sold 302 shares of common stock on September 21, 2026 for $2.97 per share.
Summary
- Open-market sale: disposed of 302 Class A Common Stock at $2.97 ($898) on September 21, 2026; holds 18,500 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $898 of stock on the open market.
Insider Transactions
Jason A. Leverone — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Open-market sale | Class A Common Stock | 302 | $3 | $898 | 18,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Open-market sale (302 shares) |
Keywords
insider transaction, Form 4, OKUR, OnKure Therapeutics, Inc., bearish, Jason A. Leverone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.